Ascending Investigator Grant within Endocrinology and Metabolism – Nordic Region supports mid-career research leaders studying endocrinology and metabolism to advance human health and disease treatment or prevention.
Funder: Novo Nordisk Foundation
Due Dates: January 19, 2027, 2:00pm Copenhagen time (Application deadline) | May 2027 (Results)
Funding Amounts: Up to DKK 12.5 million over five years; up to DKK 50 million available
Summary: Supports independent, mid-career research leaders in the Nordic region advancing endocrinology and metabolism research relevant to human health.
Key Information: Applicants must lead their own research group and cannot hold or have been offered a professorship.
The Novo Nordisk Foundation supports accomplished associate professors and equivalent research leaders in consolidating their groups and developing ambitious research programmes at a high international level. The grant funds basic, experimental, clinical and translational research that advances understanding of the human organism and improves disease treatment or prevention through endocrinology and metabolism.
Research may involve patients, clinical practice, animal models, model organisms, cellular or sub-cellular systems with clear whole-body relevance, or in silico analysis. The scope includes cellular energy homeostasis and hormonal disorders across endocrinology—not only diabetes, but also thyroid research, reproduction, and bone and calcium metabolism. Projects should be novel, scientifically excellent and potentially high-impact, justifying five years of support.